Literature DB >> 17024012

Pathogenesis of Helicobacter pylori infection.

D J McGee1, H L Mobley.   

Abstract

Helicobacter pylori, a gram-negative, microaerophilic, motile, spiral-shaped bacterium, has been established as the etiologic agent of gastritis and peptic ulcers and is a major risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (MALT). The ability of H. pylori to cause this spectrum of diseases depends on host, bacterial, and environmental factors. Bacterial factors critical for H. pylori colonization of the gastric mucosa include urease, flagella, adhesins, and delta-glutamyltranspeptidase. Lipopolysaccharide, urease, and vacuolating cytotoxin are among the factors that allow H. pylori to persist for decades and invoke an intense inflammatory response, leading to damaged host cells. Genes in the cag pathogenicity island also contribute to the inflammatory response by initiating a signal transduction cascade, resulting in interleukin-8 production. Proinflammatory cytokines and a Th-1 cytokine response further exacerbates the inflammation. Products of the enzymes nitric oxide synthase (iNOS) and cyclooxygenase may perturb the balance between gastric epithelial cell apoptosis (ulcer formation) and proliferation (cancer). The host Th-1 response and antibodies directed against H. pylori do not eliminate the organism, which presents challenges to vaccine development. Vaccines that include urease have shown some promise, but improved adjuvants and animal models should hasten progress in vaccine research. H. pylori is the most genetically diverse organism known, and the panmictic population structure may contribute to the varying ranges of disease severity produced by different strains. The complete genome sequence of two strains of H. pylori has propelled this field forward, and numerous groups are now using genomic, proteomic, and mutagenetic approaches to identify new virulence genes. Discovered only in 1982, H. pylori is now among the most intensely investigated organisms. This review summarizes recent progress in this rapidly moving field.

Entities:  

Year:  2000        PMID: 17024012     DOI: 10.1097/00001574-200001000-00005

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  19 in total

Review 1.  Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer.

Authors:  Acacia Lamb; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2013-03       Impact factor: 4.429

2.  Diversity of Helicobacter Pylori cagA and vacA Genes and Its Relationship with Clinical Outcomes in Azerbaijan, Iran.

Authors:  Reza Ghotaslou; Morteza Milani; Mohammad Taghi Akhi; Mohammad Reza Nahaei; Alka Hasani; Mohammad Saeid Hejazi; Mohammad Meshkini
Journal:  Adv Pharm Bull       Date:  2013-02-07

3.  Identification of S-nitrosylation of proteins of Helicobacter pylori in response to nitric oxide stress.

Authors:  Wei Qu; Yabin Zhou; Yundong Sun; Ming Fang; Han Yu; Wenjuan Li; Zhifang Liu; Jiping Zeng; Chunyan Chen; Chengjiang Gao; Jihui Jia
Journal:  J Microbiol       Date:  2011-05-03       Impact factor: 3.422

4.  Helicobacter pylori arginase mutant colonizes arginase II knockout mice.

Authors:  Songhee H Kim; Melanie L Langford; Jean-Luc Boucher; Traci L Testerman; David J McGee
Journal:  World J Gastroenterol       Date:  2011-07-28       Impact factor: 5.742

5.  A Five-Year-Old Boy with Marked Hypergastrinemia Associated with H. pylori Infection.

Authors:  Asako Nakata; Hitoshi Tajiri; Yuri Etani; Sadami Kimura; Tomoko Takano
Journal:  Case Rep Gastroenterol       Date:  2010-09-18

6.  Helicobacter pylori proteins response to nitric oxide stress.

Authors:  Wei Qu; Yabin Zhou; Chunhong Shao; Yundong Sun; Qunye Zhang; Chunyan Chen; Jihui Jia
Journal:  J Microbiol       Date:  2009-09-09       Impact factor: 3.422

7.  Helicobacter, Inflammation, and Gastric Cancer.

Authors:  Antonia R Sepulveda
Journal:  Curr Pathobiol Rep       Date:  2013-03

8.  Helicobacter pylori activates NF-κB by inducing Ubc13-mediated ubiquitination of lysine 158 of TAK1.

Authors:  Acacia Lamb; JinJing Chen; Steven R Blanke; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2013-10       Impact factor: 4.429

9.  A redox basis for metronidazole resistance in Helicobacter pylori.

Authors:  N O Kaakoush; C Asencio; F Mégraud; G L Mendz
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

Review 10.  Helicobacter pylori infection in developing countries: the burden for how long?

Authors:  Barik A Salih
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.